Microsafe, the antimicrobial commercial-grade paint developed by Hanford & Green, is now proven to help reduce SARS-COV-2, the virus that causes Covid-19, on painted surfaces. Launched in 2020, Microsafe is powered by Biomaster antimicrobial technology, already known to inhibit the growth of most common types of bacteria including antibiotic-resistant strains such as MRSA and E.coli. Hanford & Green's antimicrobial Microsafe paint with Biomaster protection provides a vital second line of defence against harmful microbes, giving surfaces extra protection beyond routine cleaning protocols. In independent tests, Microsafe reduced SARS-COV-2 on painted surfaces by up to 45% after 6 hours and up to 68% after 24 hours when compared to a control painted surface. Adam Green, Co-Founder of Hanford & Green, said: “We are thrilled to announce our Microsafe anti-microbial paint is effective inside or out without affecting the quality of the finish.
Find out more about Addmaster (UK) Ltd on their member profile page here